NIH-funded research R01 grant

Understanding how gene expression in the habenula affects opioid addiction and depression

Official title: Regulation of Gene Expression in the Human Habenula in Comorbid Opioid Addiction and Depression

Funded at Lieber Institute, INC. · NIH-11105994 · Data updated 2026-11-12

This study is looking at how certain genes in a part of the brain called the habenula, which helps control our mood and motivation, might be linked to opioid addiction and depression, with the goal of finding better ways to treat these issues.

More Depression research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLieber Institute, INC.
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJuly 1, 2022
Project endApril 30, 2027
Funding year2025
Award (this year)$680,018
NIH project number5R01DA055823-04
Project IDNIH-11105994 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are experiencing both opioid addiction and major depressive disorder.

Less likely to help

Patients who do not have a comorbidity of opioid addiction and depression may not benefit from this research.

What this research studies

This research investigates the relationship between gene expression in the habenula, a brain region involved in motivation and mood regulation, and its role in opioid addiction and depression. By utilizing advanced technologies, the study aims to create detailed molecular maps of the habenula to identify specific cell types and their functions. This approach will help uncover the genetic and epigenetic factors that contribute to the dysfunction of this brain area in individuals suffering from both conditions. The findings could lead to new insights into how these disorders are interconnected and how they can be treated more effectively.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for patients dealing with both opioid addiction and depression.

How similar studies have gone: Other research has shown promising results in understanding the neurobiological underpinnings of addiction and depression, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Lieber Institute, INC.
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Maynard, Kristen Rose — Lieber Institute, INC.
  • Study coordinator: Maynard, Kristen Rose

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.